LU81841A1 - Nouveaux composes azotes heterocycliques - Google Patents
Nouveaux composes azotes heterocycliques Download PDFInfo
- Publication number
- LU81841A1 LU81841A1 LU81841A LU81841A LU81841A1 LU 81841 A1 LU81841 A1 LU 81841A1 LU 81841 A LU81841 A LU 81841A LU 81841 A LU81841 A LU 81841A LU 81841 A1 LU81841 A1 LU 81841A1
- Authority
- LU
- Luxembourg
- Prior art keywords
- radical
- formula
- compound
- oxo
- acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
- C07D239/90—Oxygen atoms with acyclic radicals attached in position 2 or 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
- C07D311/24—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB7842679 | 1978-10-31 | ||
| GB7842679 | 1978-10-31 | ||
| GB7920760 | 1979-06-14 | ||
| GB7920760 | 1979-06-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LU81841A1 true LU81841A1 (fr) | 1980-05-07 |
Family
ID=26269406
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LU81841A LU81841A1 (fr) | 1978-10-31 | 1979-10-30 | Nouveaux composes azotes heterocycliques |
Country Status (32)
| Country | Link |
|---|---|
| US (1) | US4419352A (es) |
| AR (1) | AR230449A1 (es) |
| AT (1) | AT379811B (es) |
| AU (1) | AU528648B2 (es) |
| BR (1) | BR7907006A (es) |
| CA (1) | CA1142520A (es) |
| CH (1) | CH643264A5 (es) |
| CS (1) | CS231166B2 (es) |
| CU (1) | CU21123A (es) |
| DD (1) | DD146954A5 (es) |
| DE (1) | DE2943658A1 (es) |
| DK (1) | DK458679A (es) |
| FI (1) | FI67702C (es) |
| FR (1) | FR2440371A1 (es) |
| GR (1) | GR73861B (es) |
| HK (1) | HK66185A (es) |
| HU (1) | HU183087B (es) |
| IE (1) | IE49464B1 (es) |
| IL (1) | IL58579A (es) |
| KE (1) | KE3540A (es) |
| LU (1) | LU81841A1 (es) |
| MA (1) | MA18631A1 (es) |
| MY (1) | MY8500439A (es) |
| NL (1) | NL7907916A (es) |
| NO (1) | NO154522C (es) |
| NZ (1) | NZ191956A (es) |
| PH (1) | PH15442A (es) |
| PL (1) | PL130691B1 (es) |
| PT (1) | PT70392A (es) |
| SE (1) | SE451071B (es) |
| SG (1) | SG40885G (es) |
| SU (1) | SU1014476A3 (es) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5260306A (en) * | 1981-07-24 | 1993-11-09 | Fisons Plc | Inhalation pharmaceuticals |
| GB8402047D0 (en) * | 1984-01-26 | 1984-02-29 | Fisons Plc | Nitrogen heterocycles |
| EP0162556B1 (en) * | 1984-04-13 | 1991-11-06 | FISONS plc | Novels forms and formulations of nedocromil sodium |
| GB8501015D0 (en) * | 1985-01-16 | 1985-02-20 | Riker Laboratories Inc | Drug |
| GB8607159D0 (en) * | 1986-03-22 | 1986-04-30 | Smith & Nephew Ass | Pharmaceutical composition |
| NL8701335A (nl) * | 1986-06-21 | 1988-01-18 | Sandoz Ag | Orale farmaceutische preparaten. |
| EP0279121B1 (en) * | 1986-12-23 | 1993-09-01 | FISONS plc | Pharmaceutical compositions comprising an aqueous solution of a pyranoquinoline derivative |
| USRE38628E1 (en) * | 1986-12-23 | 2004-10-19 | Fisons Plc | Pharmaceutical compositions |
| USH672H (en) | 1986-12-31 | 1989-09-05 | E. R. Squibb & Sons, Inc. | Stable antifungal capsule formulation |
| US4767612A (en) * | 1987-01-23 | 1988-08-30 | Rorer Pharmaceutical Corporation | Triamcinolone acetonide for the treatment of allergic rhinitis |
| GB8704089D0 (en) * | 1987-02-21 | 1987-03-25 | Fisons Plc | Method of treatment |
| GB2202145B (en) * | 1987-03-17 | 1991-01-02 | Fisons Plc | Compositions of nedocromil for dermatological use. |
| US5648084A (en) * | 1990-02-28 | 1997-07-15 | Guttag; Alvin | Multiple dosage medicine drop bottle |
| AU650036B2 (en) * | 1990-07-25 | 1994-06-09 | Teijin Limited | Benzopyran derivative, production thereof, and pharmaceutical composition containing the same |
| US5294433A (en) * | 1992-04-15 | 1994-03-15 | The Procter & Gamble Company | Use of H-2 antagonists for treatment of gingivitis |
| US5453431A (en) * | 1993-10-29 | 1995-09-26 | Gilman; Andrew L. | Use of hydroxychloroquine for treatment of graft-versus-host disease |
| ZA966579B (en) * | 1995-08-04 | 1998-02-02 | Wakamoto Pharma Co Ltd | O/W emulsion composition for eye drops. |
| US5891472A (en) * | 1996-11-19 | 1999-04-06 | Meri Charmyne Russell | Treatment of equine laminitis |
| US5989571A (en) * | 1997-07-23 | 1999-11-23 | Millenium Pharmaceutical Technologies, Inc. | Contact dermatitis pharmaceutical preparation with anti-histamine and anti-inflammatory |
| US5885550A (en) * | 1998-07-02 | 1999-03-23 | Vallier; Deandra K. | Ophthalmic whitening solution |
| US7101547B1 (en) | 1999-01-22 | 2006-09-05 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Method for the prevention and treatment of diseases caused by an inflammatory response mediated by endogenous substance P by using anti-substance P antibodies |
| AU2001264616A1 (en) * | 2000-05-17 | 2001-11-26 | Cor Therapeutics, Inc. | Methods for producing amino substituted chromanes and intermediates therefor |
| US9132116B2 (en) * | 2004-08-02 | 2015-09-15 | Willowcroft Pharm Inc. | Mast cell stabilizers to prevent or treat laminitis |
| GB0524808D0 (en) * | 2005-12-05 | 2006-01-11 | Novartis Ag | Organic compounds |
| DE102007028095A1 (de) * | 2007-06-19 | 2009-01-15 | Bachmann, Vincent | Zubereitung zur Behandlung von Hufrehe bei Equiden |
| FR2924344B1 (fr) * | 2007-12-04 | 2010-04-16 | Pf Medicament | Utilisation de la mequitazine sous la forme de racemate ou d'enantiomeres pour la preparation d'un medicament destine au traitement ou a la prevention de pathologies impliquant les recepteurs histaminiques h4. |
| EP2424527B8 (en) * | 2009-04-29 | 2019-07-17 | Willowcraft Pharm Inc. | Mast cell stabilizers to prevent or treat laminitis |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1504709A (en) * | 1974-12-07 | 1978-03-22 | Fisons Ltd | N-substituted quinolinone-2-carboxyl. acid der |
| AU513456B2 (en) * | 1977-03-08 | 1980-12-04 | Takeda Chemical Industries Ltd. | l-Azaxanthone-3-carboxylic acids |
| IL54614A (en) * | 1977-05-04 | 1983-07-31 | Fisons Ltd | Dihydrodioxo-pyranoquinoline dicarboxylic acid derivatives,their production and pharmaceutical compositions containing them |
-
1979
- 1979-10-25 FR FR7926530A patent/FR2440371A1/fr active Granted
- 1979-10-26 CA CA000338555A patent/CA1142520A/en not_active Expired
- 1979-10-26 GR GR60344A patent/GR73861B/el unknown
- 1979-10-29 BR BR7907006A patent/BR7907006A/pt unknown
- 1979-10-29 MA MA18832A patent/MA18631A1/fr unknown
- 1979-10-29 AU AU52287/79A patent/AU528648B2/en not_active Ceased
- 1979-10-29 NZ NZ191956A patent/NZ191956A/en unknown
- 1979-10-29 NO NO793469A patent/NO154522C/no unknown
- 1979-10-29 FI FI793369A patent/FI67702C/fi not_active IP Right Cessation
- 1979-10-29 NL NL7907916A patent/NL7907916A/nl not_active Application Discontinuation
- 1979-10-29 CS CS797359A patent/CS231166B2/cs unknown
- 1979-10-29 PL PL1979219304A patent/PL130691B1/pl unknown
- 1979-10-29 CU CU7935159A patent/CU21123A/es unknown
- 1979-10-29 DE DE19792943658 patent/DE2943658A1/de active Granted
- 1979-10-29 IL IL58579A patent/IL58579A/xx unknown
- 1979-10-30 AR AR278695A patent/AR230449A1/es active
- 1979-10-30 IE IE2074/79A patent/IE49464B1/en not_active IP Right Cessation
- 1979-10-30 LU LU81841A patent/LU81841A1/fr unknown
- 1979-10-30 CH CH971579A patent/CH643264A5/fr not_active IP Right Cessation
- 1979-10-30 DK DK458679A patent/DK458679A/da not_active Application Discontinuation
- 1979-10-30 PT PT70392A patent/PT70392A/pt not_active IP Right Cessation
- 1979-10-30 PH PH23228A patent/PH15442A/en unknown
- 1979-10-30 AT AT0701479A patent/AT379811B/de not_active IP Right Cessation
- 1979-10-30 DD DD79216552A patent/DD146954A5/de not_active IP Right Cessation
- 1979-10-30 HU HU79FI718A patent/HU183087B/hu not_active IP Right Cessation
- 1979-10-30 SE SE7908995A patent/SE451071B/sv not_active IP Right Cessation
- 1979-10-30 SU SU792838414A patent/SU1014476A3/ru active
-
1981
- 1981-02-20 US US06/236,329 patent/US4419352A/en not_active Expired - Fee Related
-
1985
- 1985-05-29 KE KE3540A patent/KE3540A/xx unknown
- 1985-05-30 SG SG40885A patent/SG40885G/en unknown
- 1985-09-05 HK HK661/85A patent/HK66185A/xx unknown
- 1985-12-30 MY MY439/85A patent/MY8500439A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LU81841A1 (fr) | Nouveaux composes azotes heterocycliques | |
| SU1272984A3 (ru) | Способ получени производных фталазин-4-ил-уксусной кислоты или их солей | |
| US7553853B2 (en) | Solid-state montelukast | |
| JP2021127346A (ja) | ジアザ二環式置換イミダゾピリミジンおよび呼吸障害を治療するためのその使用 | |
| JPH01279866A (ja) | キノリン系メバロノラクトン類 | |
| JPS61191683A (ja) | 新規な酸性インド−ル化合物 | |
| DE69732090T2 (de) | Indol-2,3-dione-3-oxim derivate | |
| JPH10502929A (ja) | アミン薬物用ジオキソレニルメチルカルバメート前駆成分 | |
| JPS5965036A (ja) | アラキドン酸類縁体、その製法および医薬用途 | |
| CH625511A5 (en) | Process for the preparation of new hydantoin derivatives | |
| CN101287730A (zh) | 哌嗪化合物的葡萄糖醛酸盐 | |
| CH674368A5 (es) | ||
| JP2961013B2 (ja) | 〔（アリールアルキルピペリジン−４−イル）メチル〕−２ａ，３，４，５−テトラヒドロ−１（２Ｈ）−アセナフチレン−１−オン類および関連化合物 | |
| EP3596080B1 (en) | Pharmacologically active alicyclic-substituted pyrazolo[1,5-a]pyrimidine derivatives | |
| JP3122469B2 (ja) | 抗精神病剤としてのピリジンイミニル−１，２−ベイゾイソオキサゾール類及び−ベンゾイソチアゾール類 | |
| PT535645E (pt) | Derivados carbamato de 4-amino-3-isoxazolidonas e 3-amino-1-hidroxipirrolidin-2-onas processo para a sua preparacao e sua aplicacao como medicamentos | |
| JPH0662575B2 (ja) | ジベンズアゼピン‐６‐オン化合物 | |
| JPS5982388A (ja) | １′−〔３−（１，２−ベンズイソオキサゾ−ル−３−イル）プロピル〕スピロ−〔ベンゾフラン−２−（３ｈ），３′−または４′−ピペリジンまたは３′−ピロリジン〕およびそれらの製造法 | |
| FR2536398A1 (fr) | Nouveaux composes heterocycliques | |
| GB2035312A (en) | Oxygen containing heterocylics | |
| JPH0354645B2 (es) | ||
| IE49800B1 (en) | Benzimidazolone derivatives,process for their preparation and pharmaceutical compositions containing them | |
| JPS6231704B2 (es) | ||
| JPH0365338B2 (es) | ||
| HU204264B (en) | Process for producing carbamyloxylabdanes and pharmaceutical compositions containing them |